Parametric Portfolio Associates’s Strongbridge Biopharma plc. SBBP Stock Holding History

Parametric Portfolio Associates’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-44,032	Closed	-$90K	–	3763
2021 Q3	$90K	Sell	44,032 -12,553	-22%	-$29.2K	﹤0.01%	3546
2021 Q2	$168K	Sell	56,585 -4,985	-8%	-$13.2K	﹤0.01%	3430
2021 Q1	$170K	Sell	61,570 -2,578	-4%	-$7.78K	﹤0.01%	3910
2020 Q4	$156K	Buy	64,148 +6,936	+12%	+$16.7K	﹤0.01%	3833
2020 Q3	$120K	Sell	57,212 -4,810	-8%	-$16.2K	﹤0.01%	3761
2020 Q2	$234K	Sell	62,022 -48,282	-44%	-$145K	﹤0.01%	3570
2020 Q1	$208K	Buy	110,304 +705	+0.6%	+$1.83K	﹤0.01%	3540
2019 Q4	$229K	Buy	109,599 +60,326	+122%	+$116K	﹤0.01%	3689
2019 Q3	$118K	Buy	49,273 +13,480	+38%	+$36.2K	﹤0.01%	3809
2019 Q2	$112K	Buy	+35,793	New	+$131K	﹤0.01%	3831

Parametric Portfolio Associates's SBBP Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 44,032 shares — an estimated $90K sold.

Parametric Portfolio Associates first reported a position in SBBP in Q2 2019 and held it in 10 quarters. The position peaked at $234K in Q2 2020. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

Parametric Portfolio Associates reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 44,032 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $90K.
Parametric Portfolio Associates first reported a position in Strongbridge Biopharma plc. in Q2 2019 and held it in 10 quarters.
Parametric Portfolio Associates's Strongbridge Biopharma plc. position peaked at $234K in Q2 2020.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.